Nutritional genomics

BMJ

Volumn 324, Issue 7351, 2002, Pages 1438-

  Elliott, Ruan ^a   Ong, Teng Jin ^b  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b Clinical Research development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE METABOLISM; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; FOLATE METABOLISM; FOOD QUALITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; HIGH RISK POPULATION; HUMAN; IMMUNE SYSTEM; IRON METABOLISM; LIPID METABOLISM; NUTRITION; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; DIET; FEEDING BEHAVIOR;

DIET; DIETARY SUPPLEMENTS; FOOD HABITS; FOOD, FORTIFIED; GENOMICS; HUMANS; NUTRITION PHYSIOLOGY; VARIATION (GENETICS);

EID: 0037098670     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.324.7351.1438     Document Type: Article

References (24)

1. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921.
2. International SNP Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928–933.
3. World Cancer Research Fund and American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Menasha: BANTA Book Group, 1997.
4. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1–29.
5. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1191–1308.
6. Peterson J, Dwyer J. Flavonoids: dietary occurrence and biochemical activity. Nutr Res 1998; 18: 1995–2018.
7. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, et al. Progress in cancer chemoprevention: development of diet-related chemopreventive agents. J Nutr 2000; 130(suppl):467–71S.
8. Eisen MB, Brown PO. DNA arrays for analysis of gene expression. Methods Enzymol 1999; 303: 179–205.
9. Dongre AR, Opiteck G, Cosand WL, Hefta SA. Proteomics in the post-genome era. Biopolymers 2001; 60: 206–211
10. Nicholson JK, Connely J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nature Drug Discovery (in press).
11. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001; 22: 195–201.
12. Moyers S, Bailey LB. Fetal malformations and folate metabolism: review of recent evidence. Nutr Rev 2001; 59: 215–235.
13. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am J Gastrointest Liver Physiol 2001; 282: G403–G414.
14. Stewart TL, Ralston SH. Review of genetic factors in the pathogenesis of osteoporosis. J Endocrinol 2000; 166: 235–245.
15. Ye SQ, Kwiterovich PO. Influence of genetic polymorphisms on responsiveness to dietary fat and cholesterol. Am J Clin Nutr 2000; 72(suppl):1275–184S.
16. Howell WM, Turner SJ, Hourihane JO, Dean TP, Warner JO. HLA class II DRB1, DQB1 and DPB1 genotypic associations with peanut allergy: evidence from a family-based and case-control study. Clin Exp Allergy 1998; 28: 156–162.
17. Nguyen TV, Blangero J, Eisman JA. Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res 2000; 15: 392–401.
18. Mathew C. Postgenomic technologies: hunting the genes for common disorders. BMJ 2001; 322: 1031–1034.
19. Groziak SM, Miller GD. Natural bioactive substances in milk and colostrums: effects on the arterial blood pressure system. Br J Nutr 2000; 84(suppl 1):S119–S125.
20. Baudin B. Angiotensin I-converting enzyme gene polymorphism and drug response. Clin Chem Lab Med 2000; 38: 853–856.
21. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for the treatment of osteoarthritis. JAMA 2000; 283: 1469–1475.
22. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: randomised, placebo-controlled clinical trial. Lancet 2001; 357: 251–256.
23. Chard J, Dieppe P. Glucosamine for osteoarthritis: magic, hype, or confusion? BMJ 2001; 322: 1439–1440.
24. Towheed TE, Anastassiades TP, Shea B, Houpt J, Welch V, Hochberg MC. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2001;(1):CD002946